1. European Commission: Regulation (EC) No. 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products.Official Journal of the European CommunitiesL18/1–L18/5 (2000).
2. European Medicines Agency: fee reductions for designated orphan medicinal products. EMA/960144/2011. European Medicines Agency, London, UK (2011).
3. European Commission: guideline on aspects of the application of Article 8(2) of Regulation (EC) No. 141/2000: review of the period of market exclusivity of orphan medicinal products.Official Journal of the European CommunitiesC242/8–C242/11 (2008).
4. EURORDIS position paper: why research on rare diseases? EURORDIS, Paris, France (2010).
5. European Commission: Council Directive 89/341/EEC of 3 May 1989 amending Directives 65/65/EEC, 75/318/EEC and 75/319/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products.Official Journal of the European CommunitiesL142/11–L142/13 (1989).